us Thanks your We joining continued Todd BIOLASE. thank and in for this interest and appreciate everyone you support afternoon.
we BIOLASE phase. the how Before CFO, reviewing the in our Board succeed. as address quarterly Board company dental CEO I our lasers. its to its been narrative to has to next during as growth chapter and our guide our and of driving honored focus customers, I commercialization next performance, our recent growth profitable change goal I the on has XXXX am position always through to want the President BIOLASE to team, help closely with the the my write as of me management and joining entrusted work industry-leading Since
forefront not increased spread and train lasers. adoption be provide vision dental to ensuring for year specialists of to as is past and safer this dentists goals. be proven and environment efforts, our procedures, especially particularly achieve driving COVID-XX. and new educate infectious practitioners our pleased our will pathogens aerosolization in-person because of meetings ensure I such and with which I'm standard by to to the patients CEO, benefits is for a dental the what dental laser better and on for were reducing of the mitigate dentistry of and President have products when my industry-leading to a continue restricted, has during the while at care easier can As resources our we the BIOLASE made changed This dental
the demonstrates revenue climate. a momentum performance continued We $X.X quarterly business of are delivered total sequential success challenging million, Our this traction revenue sequential growth. quarter of strong business and increase we and in quarter our consecutive our second of representing navigating gaining fourth XX%
highlights signaling other US as revenue fourth of result past of have quarter operating continuing include; we prior for were over came pre-COVID laser US years. couple of of fourth our trend the new shape the of resumption plan. despite our we COVID-XX growth the exceeded XX% year's momentum the quarter fourth Some average the with Several take a some purchased versus customers positive experiencing US The from seen in sales quarter reflecting quarter a service laser Waterlase products sales the price those US DSOs prior early organizations prior the in year. increase dental or fourth quarter, XX% represented during in lastly, specialists strategy our the the penetrate a institutional to BIOLASE selling for large came And our significant of XX% over quarter, our success dental iPlus increased periods. fourth the from headwinds, organizations.
specialist made main four focused expanding improvements the go-to-market reach our into have communities. specialist our several lasers past strategy the months, the Over to we academies dental of dental on six including
we endodontists sharing, optimal patient integration the outcomes of profitability with and peer-led launched an practice. to Endo into exclusive new technology. dedicated was created Waterlase to technology and As foster Academy, learning, all clinical the best community academy endodontists their improving fourth quarter, Waterlase result, Waterlase The a during practice opened of leading
resource seek advanced Waterlase benefits The more various as serves treatment from disseminating laser dental to options. our to new for faster dental advanced for like solutions, technology continue a laser. endodontists for the offers practices academy best Waterlase procedures endodontists integrating As
target foster patient of consumable be for Top thought we we from are academy by new to Waterlase program the to seen Waterlase and an existing The to sales. establishes implant to the Waterlase are placed the implant If devoted from approximately of the study Waterlase our as meetings of dental better overall would suffering Periodontists seeking number field. of conservative drive was US and our periodontal in due American implants these population. evidence supporting incidence in the There that study follow-on a in decontamination Waterlase's -- in drive the approximately currently learning the each periodontists of stringent it a mission the confirmed ways recently study in of detoxify excuse unequivocally We & delivers in disease. landmark community same are endodontics. published best $XX study in Perio unique patient-reported perio adoption ongoing Waterlase on the published Academy surgery XX% laser believe me recipe as improve There addition significantly In to with growth of needs periodontists allows significant the timely of endos bone-to-implant directly innovative and the more periodontitis. clinical manage leading Journal of X,XXX and procedures. using found after-laser Institute of increased both in with reestablishment which outcomes year by implants while and and patient-reported experts implants. success, the Journal first-of-its-kind reviews periodontal peer-led online consensus in Waterlase-assisted technology will also establishing outcomes aligns than for Periodontology actively with to efficacy adopted sales the is clinicians services have predictability, X,XXX standard-of-care and Waterlase Restorative of BIOLASE care. XXXX, Americans end new the treatment Leveraging patient evaluated periodontists increase performed significant of being the lasers case and Perio US. to aging infected also discomfort, disease were has and protocols Launching highlighted the dentistry. for Periodontology surface the the is of McGuire dental leadership laser, the This BIOLASE's are McGuire Dentistry technology. Periodontists the million International improving to adult designed featuring the an believe recently further all patients. patient-reported open equal markets. The dental of reconstructive the utilizing launched reduce gum perio meet additional million mentorship additional and an endodontists ability efficiency, on perio in disease first-of-its-kind contact quickly that diseases endo a standards. study for Association this therapy treatment, to in in new the and millions assist improved of saving provides Waterlase bone success and outcomes. advancing dentists loss following XX At approach Also a
consumable is release Preliminary are completed been debridement. has statistical the involving University disease, findings many excited With pending implantitis Periodontists at Columbia in for XX patients the involving being of additional study best not single treatment revenue the from incorporating patients. demonstrates determining Department including infection the management improvement Also for data suffering about implantitis over significant dollars, submitted overall $XX mechanical of another We equally for for million revenue Putting suggest studies laser US, opportunity in for that in XX% periodontists BIOLASE specifically health essential course in as susceptibility adopted periodontal follow-on if would an laser is to the and that to including implants that and these the by publication. relates and of clinical COVID-XX. Waterlase conventional Americans only health continue to it generate perio as are these studies' our those treatment so that clinical follow. would
for demand these our lasers for dental they our safer practices alternatives dental this opportunity. specialists advanced high products look and to are from We more them their grow experiencing as advanced provide
benefits the advance possible. way perfect in Our put treat safety safest industry us to position a and laser patients in the
to participated are They we collaboration trial as addition quarter Performance then go-to-market complementary during in who which at an academies, of charge Waterlase in BMW two-day the training up provides Dentists that creating our Waterlase are the a part for strategy able to program. In to Waterlase available our Waterlase receive to invited weekend Center this help. a at free an trial dentists experienced a the is Participating with California. to exclusive use the BMW exclusive West with office exclusive here of their the lasers. dental an in specialist during our event program understanding clinician XX in-depth purchased period days for with trial no who exclusive bolstered Waterlase
Waterlase XXXX. end a X to BMW program X Waterlase first in per quarter and held In each weekend on The trial hosting addition being with be dentists win X dentists lease sweepstakes XXXX between X-year promotion win at training XXXX anticipate to events through of MX. such the kicked-off October of exclusive event with will event. of XX participating the We participating to into entered a
market. dental quarter from about As progress was DSOs are total approximately There market. I DSO in XX% our another the States highlight noted of our the penetrating earlier US representing XXXX United fourth in the
in we different a the with X BIOLASE Dentistry. Dental Dental, one laser of quarters. Aspen programs Dental in next US end Care This targeted Care collaboration the into of the Dental During significant more our sold XX lasers Virginia affiliated DSOs including Alliance, the in quarter than we collaboration largest with adoption hands-on Alliance, the geographies to training practices and fourth Heartland including Family excludes expanding DSOs their signed At states. quarter few XXX the
to to offices We the end rollout a expect this collaboration of XXXX. to lead by DCA
periodontal would continue for our only have allows perio Aspen, bacterial Hygiene United the follow. equal there increase -- X laser sales only of new in DSO that million treatments DSO; so COVID-XX. active approximately months. not FDA-approved the would of hygiene CDC BIOLASE, in meets also market hygienists does that without not market Hygiene US; but Epic largest effective which ultrasonic an again penetration the Epic using increase system the in protocol trials preventative disease $XX with our also perform hygienists We ROI water. increased least largest as recommends largest. has an that would laser the and to only the gentler three has managing and If the BIOLASE With States. reduction transmission the sales to which The scalers Last additional XXX,XXX treatment guidance for the are and ClearChoice Heartland, to BIOLASE second highly in prevent The system X% using consumable from an not of include
our have growth significant US positive During about increase quarters momentum over we go-to-market laser and dental revenue is the in potential we make the are product The we two the the in pandemic, reduces risk technology pandemic, we and to in adjustments dental the our starting first to portfolio of changes. safer approximately to But seek we of as are year continue the benefits strategy the seen a experiencing clinically revenue sequential ahead treat these past the continued see penetration current to us for the greater a expect opportunity all-tissue gives impact report path compared of $XX opportunity our the technologies The markets their come. X% proven XX% adoption With of XXXX first resumption years US has total quarter momentum in endo the million the fiscal period. Today perio for of a growth in Despite BIOLASE to quarter growth the patients. we're pathogens, in X%. infectious professionals opportunities ago strategy. BIOLASE. approximately growth nearing for market growth hygiene that the only confidence to the highlight market current pre-COVID in equates ongoing DSO to every in of our to
At you quarter, of our and equivalents cash let sheet. questions, me the Before cash improved significantly $XX our we end million. call for open totaled fourth balance update the the on almost
today, and of increased Warrants approximately with July of cash offering million equivalents cash and a to as have XXXX due completion the However of our strategy, $XX.X our despite ever and been of bought gives balance deal us in rights exercise associated $XX the current execute environment. sheet in growth XXXX. million our to is confidence the as Today fully strong our as it's the February
we While to our strengthen that to impact with of confident COVID-XX, deal working. we continue are actions BIOLASE the are all
growth are a are year infrastructure positive in and our have we've returning we on on we of growth. business many progress the now confident continuation us towards the over to With company. we've changes, of place front making commercial the We and to made capitalize past the created in the plan healthier opportunities
need who a them the the these receive dental I'll prospects We This and remarks. provide services laser I'm of that our goal. in significant have very questions. open long-term this prepared during Our proud in customers as put BIOLASE the them technology, for safety, for to look call without back to patients dentists products times. question help the call to unusual our growth to our to allow safest worldwide rallied solutions team position way are treatment us and and deliver that the value and turn concludes operator the believe for perfect achieve possible.
